DMPI - DelMar Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development5,003.643,360.8782,555.754
Selling General and Administrative3,317.1892,853.142,168.899
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-8,320.829-6,214.018-4,724.653
Income from Continuing Operations
Total Other Income/Expenses Net239.065-2,650.846378.977
Earnings Before Interest and Taxes-8,081.764-8,864.864-4,345.676
Interest Expense--2.091
Income Before Tax-8,081.764-8,864.864-4,347.767
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-8,081.764-8,864.864-4,347.767
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-8,081.764-8,864.864-4,347.767
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-8,872.218-9,103.19-4,347.767